Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2015. Module: SNOMED CT United Kingdom clinical extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 763191000000115 | [X]Predominantly alpha-adrenoreceptor agonists causing adverse effects in therapeutic use, not elsewhere classified (disorder) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom clinical extension module |
| 935471000000112 | [X]Predominantly alpha-adrenoreceptor agonists causing adverse effects in therapeutic use, not elsewhere classified | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom clinical extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| [X]Predominantly alpha-adrenoreceptor agonists causing adverse effects in therapeutic use, not elsewhere classified | Is a | Alpha-adrenoceptor agonist adverse reaction | false | Inferred relationship | Existential restriction modifier | ||
| [X]Predominantly alpha-adrenoreceptor agonists causing adverse effects in therapeutic use, not elsewhere classified | Is a | [X]Other and unspecified drugs primarily affecting the autonomic nervous system causing adverse effects in therapeutic use | false | Inferred relationship | Existential restriction modifier | ||
| [X]Predominantly alpha-adrenoreceptor agonists causing adverse effects in therapeutic use, not elsewhere classified | Causative agent | Substance with alpha adrenergic receptor agonist mechanism of action | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR